A case of vitiligo after COVID-19 vaccination: a possible role of thymic dysfunction

作     者：Denis KUZNETSOV Oleg KALYUZHIN Andrey MIRONOV Valery NESCHISLIAEV Anastasiia KUZNETSOVA Denis KUZNETSOV;Oleg KALYUZHIN;Andrey MIRONOV;Valery NESCHISLIAEV;Anastasiia KUZNETSOVA

作者机构：G.N.Gabrichevsky Scientific and Research Institute of Epidemiology and MicrobiologyMoscow 125212Russia I.M.Sechenov First Moscow State Medical UniversityMoscow 119991Russia Perm State Pharmaceutical AcademyPerm 614990Russia 

出 版 物：《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》 (浙江大学学报（英文版）B辑（生物医学与生物技术）)

年 卷 期：2023年第24卷第12期

页      面：1141-1150页

核心收录：

学科分类：0710[理学-生物学] 1004[医学-公共卫生与预防医学(可授医学、理学学位)] 1002[医学-临床医学] 1001[医学-基础医学(可授医学、理学学位)] 100401[医学-流行病与卫生统计学] 0836[工学-生物工程] 10[医学] 

主　　题：vaccination vaccines 

摘      要：During the coronavirus disease 2019(COVID-19)pandemic,vaccines help control the spread of infection.To date,47 vaccines have been approved,with another 227 candidates in various stages of development.In the short period of time since the beginning of their use,evidence has begun to emerge of complications following vaccination in the form of the development or exacerbation of a number of pathological conditions(Block et al.,2022;Haseeb et al.,2022).For example,a population-based study in France identified 1612 cases of myocarditis and 1613 cases of pericarditis requiring hospital treatment within five months of vaccination(le Vu et al.,2022).